Advanced Search

 

Study ID Status Title Patient Level Data
201223 Active, Not Recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752
201234 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) compared to Fluzone® Quadrivalent in children 6 to 35 months of age Study Listed on ClinicalStudyDataRequest.com
201235 Completed PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
201244 Completed A randomized, double-blinded study to evaluate the ability of an acne treatment product to produce visible improvements in acne lesions over a 5 day period of once-daily use
201251 Completed Safety and immunogenicity study of GSK Biologicals’ Quadrivalent Influenza Candidate Vaccine (GSK23211381A) manufactured with a new process in adults and children
201280 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC versus other treatments for COPD adult patients
201295 Active, not recruiting Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of COMPARZ Data
201302 Terminated A Phase 1 double-blind, randomised, placebo-controlled, dose escalating study to assess the safety and tolerability of single and multiple oral doses of CHR-5154 and the effect of the fasted and fed state on pharmacokinetics of CHR-5154 and CHR-5426 in healthy male volunteers
201314 Completed A randomized, parallel group study to evaluate the effect of Umeclidinium (UMEC) added to Inhaled corticosteroid/ long-acting beta-agonist combination therapy in subjects with Chronic Obstructive Pulmonary Disease COPD Study Listed on ClinicalStudyDataRequest.com
201315 Completed A Randomized, Parallel-group, Open-label Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Glycopyrronium 44 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
201316 Completed A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Tiotropium 18 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
201317 Completed A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effect of the Combination of Umeclidinium and Vilanterol on Exercise Endurance Time in Subjects with COPD
201357 Active, not recruiting Health care resource use and costs associated with use of mepolizumab versus placebo in a clinical trial setting
201358 Active, not recruiting Systematic Literature Review and Meta-Analysis of Side Effects of Treatments Used in Advanced Soft Tissue Sarcoma
201363 Completed Treatment Pathways in an Inception Lupus Cohort in Atlantic Canada
201373 Completed Characterization of patients with Chronic Lymphocytic Leukemia in British Columbia, Canada using a province-wide CLL database
201376 Active, not recruiting Understanding Current Patterns of Care and Planning for the Future – A Retrospective Observtional Study in Melanoma
201379 Active, Not Recruiting Patterns of Care for Patients with Metastatic Renal Cell Carcinoma in a United States Population
201402 Completed A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions Study Listed on ClinicalStudyDataRequest.com
201426 Completed PRJ2250: Survey of patient and prescriber understanding of risks associated with TROBALT
201474 Completed A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
201477 Completed Duration of Protection Following Five Doses of GlaxoSmithKline’s (GSK’s) DTaP Vaccines in School Age Children
201496 Completed 201496: A Study to Evaluate the Efficacy and Safety of 15mg BID Losmapimod (GW856553) Compared to Placebo in Frequently Exacerbating Subjects with Chronic Obstructive Pulmonary Disease (COPD)
201512 Active, not recruiting Clinical and economic outcomes associated with use of fluticasone propionate 250 mcg and salmeterol 50 mcg combination versus tiotropium as initial maintenance treatment for chronic obstructive pulmonary disease in a managed care setting
201514 Active, Not Recruiting Impact of initiating maintenance treatment (MT) promptly post-chronic obstructive pulmonary disease (COPD) exacerbation in a managed care setting

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.